Ayala Pharmaceuticals Inc (ADXS): What constitutes as "super offer" IYO?...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	230
Boards Moderated	0
Alias Born	10/13/2016

investisbest

Re: samk post# 15719

Thursday, 03/16/2017 4:40:37 PM

Thursday, March 16, 2017 4:40:37 PM

What constitutes as "super offer" IYO? Here is how I see things potentially unfolding:

1. Significant news announcement within weeks that propels the market cap to over 1B (somewhere between $30-$40 ps)

2. Then, trending up over the course of the next several months towards a 2B+ MC, which is about $50-$60 ps

From here (market cap of 2B+) is fair value IMO. Now, today the data continues to strongly point to the fact that this isn't just "another" platform for treating cancer. This is a transformational , game-changing, or rather "the next 'killer-app'" in the world of BIO.

And, if true, anything less than an offer 10+ Billion is selling the the technology short. Frankly, I'd rather see Advaxis grow and end up becoming a multi-billion dollar giant one day than selling off for a few billion.

Either way, times are getting exciting...